Listar por tema "malignant neoplasm"

Mostrando ítems 1-5 de 5

The catalytic role of a research university and international partnerships in building research capacity in Peru: A bibliometric analysis.

Belter, Christopher W.; Garcia Funegra, Patricia Jannet; Livinski, Alicia A.; León-Velarde, Fabiola; Weymouth, Kristen H.; Glass, Roger I. (Public Library of Science, 2019)

Objective: In Peru, the past three decades have witnessed impressive growth in biomedical research catalyzed from a single research university and its investigators who secured international partnerships and funding. We ...
A divergence between underlying and final causes of death in selected conditions: An analysis of death registries in Peru

Carrillo Larco, Rodrigo Martín; Bernabé Ortiz, Antonio (PeerJ, 2018)

Background: The underlying cause of death is used to study country and global mortality trends and profiles. The final cause of death could also inform the ultimately cause of death in individuals with underlying conditions. ...
Healthy survival after tuberculosis.

Datta, Sumona; Evans, Carlton Anthony William (Elsevier, 2019)

WHO estimates that 1·6 million people die each year before or during tuberculosis treatment. In The Lancet Infectious Diseases, Kamila Romanowski and colleagues' meta-analysis showed that tuberculosis survivors have ...
Latin America and the Caribbean Code Against Cancer: Developing Evidence-Based Recommendations to Reduce the Risk of Cancer in Latin America and the Caribbean

Cazap, Eduardo; de Almeida, Liz Maria; Arrossi, Silvina; Garcia Funegra, Patricia Jannet; Garmendia, Maria Luisa; Gil, Enrique; Hassel, Trevor; Mayorga, Ruben; Mohar, Alejandro; Murillo, Raul; Owen, Gabriel O.; Paonessa, Diego; Santamaria, Julio; Tortolero-Luna, Guillermo; Zoss, Walter; Herrero, Rolando; Luciani, Silvana; Schuz, Joachim; Espina, Carolina (American Society of Clinical Oncology, 2019)

Latin America and the Caribbean (LAC) has a population of more than 650 million inhabitants (8.5% of the world population), with a cancer incidence of more than 1.4 million new patients and more than 670,000 deaths in 2018. ...
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial

Suh, Chang-Hee; Yoo, Dae Hyun; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elia; Cons Molina, Francisco Fidenci; Shesternya, Pavel; Miranda, Pedro; Medina-Rodriguez, Francisco G.; Wiland, Piotr; Jeka, Slawomir; Chavez-Corrales, Jose; Linde, Thomas; Hrycaj, Pawel; Abello-Banfi, Mauricio; Hospodarskyy, Ihor; Jaworski, Janusz; Piotrowski, Mariusz; Brzosko, Marek; Krogulec, Marek; Shevchuk, Sergii; Calvo, Armando; Andersone, Daina; Park, Won; Shim, Seung Cheol; Lee, Sang Joon; Lee, Sung Young (Springer, 2019)

Objective: The aim of this study was to investigate long-term clinical outcomes of extended treatment with CT-P10, a rituximab biosimilar, compared with rituximab reference products sourced from the USA and the EU (US-RTX ...

Listar por tema "malignant neoplasm"

Listar por tema "malignant neoplasm"

Buscar en el Repositorio

Listar

Todo el Repositorio

Panel de Control